Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1–2) on chronic kidney disease (stages 2–4): A multicenter randomized controlled clinical trial

Lack of effective drugs for acute kidney injury (AKI) grades 1–2 is a crucial challenge in clinic. Our previously single-center clinical studies indicated Chuan Huang Fang (CHF) might have nephroprotection in AKI on chronic kidney disease (CKD) (A on C) patients by preventing oxidant damage and inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ling, Ye, Zi, Wang, Danjun, Liu, Jianlian, Wang, Qian, Wang, Chen, Xu, Bing, Gong, Xuezhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573953/
https://www.ncbi.nlm.nih.gov/pubmed/36263137
http://dx.doi.org/10.3389/fphar.2022.969107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573953/
https://www.ncbi.nlm.nih.gov/pubmed/36263137
http://dx.doi.org/10.3389/fphar.2022.969107

Ejemplares similares